Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Andrew Hantel, Md

Clinical trials sponsored by Andrew Hantel, Md, explained in plain language.

Not yet recruiting 1
Sort by
  • New dosing guidelines aim to cut cancer treatment disruptions for duffy null patients

    Disease control Not yet recruiting

    This study tests whether using special dosing guidelines for people with the Duffy null blood type can reduce or delay the need to lower or pause their cancer drugs, and lower the risk of fever from low white blood cells. It includes 90 adults with multiple myeloma or triple-nega…

    Phase: PHASE1 • Sponsor: Andrew Hantel, MD • Aim: Disease control

    Last updated May 17, 2026 04:44 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space